Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additionally, 18 genes were found to be specifically associated with treatment response in CD and 41 related to disease complications (Table 3).Other genes associated with CD for diverse categories. * Retrieved from GWASCatalog. + Retrieved from a panelCategoryFeatureGenes (Abstracts)GWAS evidence within the geneSNP within gene associated to CD from GWASLRRK2 (19), STAT4 (14), IFNGR2 (3)*, CYLD (2), CLEC16A (2), LY75 (2), TLR8 (2), ZMIZ1 (2), CXCL12 (2), ZAP70 (2)+, TLR10 (2), PER3 (2), MTMR3 (2), MAGI1 (2), CD40 (2)*, TAB1 (1), CDYL2 (1), ELF1 (1)*, NLRP11 (1), IL2RB (1), MAP3K1 (1), TIMMDC1 (1), PDE2A (1), PRKCQ (1), SLC22A23 (1), TLE1 (1), TRPM2 (1), MORC4 (1), CYP4F2 (1), CLCA2 (1), SLC23A1 (1), GCKR (2)*, IL18RAP (4)*, BRD2 (2)*, INAVA (1)*, IL2RA (4)*+, SP140 (1)*, ITLN1 (1)*, BACH2 (4)*, GPR65 (2)*, IL1RL1 (4)*, PUS10 (1)*, ANKRD55*, OSMR*, CDH13*, DENND1B*, DNMT3A*, FOSL2*, JAZF1*, KSR1*, LPP*, TAB2*, NDFIP1*, NFATC1*, PLCL1*, RFT1*, RSPO3*, SLAMF8*, THADA*, UBE3D*, ADCY3*BANK1*,BSN*,CDC37*, DAP*,FCGR2A*,HORMAD2*,PLA2G4A*,SMURF1*,TRAF3IP2*,TSPAN14*Genetic evidence in treatment responseAzathioprineTPMT (41), ITPA (4), GSTA1 (1)Anti-TNFTLR2 (26), IFNGR1 (2), TBX21 (2)InfliximabFCGR3A (11), IL17F + (7), CASP9 (7), ADAM17 + (3), TRAF3IP2 (2), FCGR1A (1), TNFAIP6 (1), ZNF133 (1)Corticosteroid dependency and resistanceNR3C1 (5)ThiopurineNUDT15 (7), NAT1 (2)Immunosuppressive therapy necessityIL1R1 (4)Genetic evidence in related complicationsSurgical interventionHSPA2 (6), CHRNA5 (1), CNTF (1), MMP9 (1), TSPAN14 (1), SMURF1 (1)Structuring behavior /Aggressive disease progressionSERPINE1 (4), IDO1 (2), SELL (2), HLA-DOA (1), CSF2RA (1), CYBA (1), FAAH (1), ZBTB44 (1), CACNA1E (1), XPO1 (1), KIAA1614 (1), SULF2 (1)Food intoleranceFOXO3 (3),(mustard, ginger, tomatoes, wasabi)TNF productionNLRP12 (3)Granuloma formationATG4A (2), ATG2A (1), ATG4D (1), FNBP1L (1)Develop CD before 40 years of ageCNR1 (2)Bone mineral densityCOL1A1 (2)Ileal CDFUT3 (2), MIR196A2 (2), MIR122 (1)Variation of GMSI levelRCL1 (1)Pouch outcomeDAGLB (1)Vitamin D levelsSCUBE3 (1), PHF11 (1)Fibrostenotic CDPRPF31 (1)Favorable disease recurrenceTIMP2 (1), CYP26B1 (1)Tuberculosis and CDIL22RA1 (1)Stenotic complicationsMMP3 (1), MMP1 (1)Linear growth affectedDYM (1)Colon location in CDMIR124: 1 (1)

Source: Classification and identification of CD genes. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A systematic review and functional bioinformatics analysis of genes associated with Crohn’s disease identify more than 120 related genes

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A systematic review and functional bioinformatics analysis of genes associated with Crohn’s disease identify more than 120 related genes

Systematic review · BMC Genomics · 2022

Original publication title

A systematic review and functional bioinformatics analysis of genes associated with Crohn’s disease identify more than 120 related genes

Debora Garza-Hernandez; Maricruz Sepulveda-Villegas; Jose Garcia-Pelaez; Raul Aguirre-Gamboa; Peter L. Lakatos; Karol Estrada; Manuel Martinez-Vazquez; Victor Trevino

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We identified a total of 126 genes from PubMed and 71 from GWAS that showed evidence of association to diagnosis, 18 to treatment response, and 41 to disease complications in Crohn’s disease. This prioritized gene catalog can be explored at http://victortrevino.bioinformatics.mx/CrohnDisease.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Crohn’s disease is one of the two categories of inflammatory bowel diseases that affect the gastrointestinal tract. The heritability estimate has been reported to be 0.75. Several genes linked to Crohn’s disease risk have been identified using a plethora of strategies such as linkage-based studies, candidate gene association studies, and lately through genome-wide association studies (GWAS). Nevertheless, to our knowledge, a compendium of all the genes that have been associated with CD is lacking.

Source: Background

Abstract: What methods does the paper describe?

We conducted functional analyses of a gene set generated from a systematic review where genes potentially related to CD found in the literature were analyzed and classified depending on the genetic evidence reported and putative biological function. For this, we retrieved and analyzed 2496 abstracts comprising 1067 human genes plus 22 publications regarding 133 genes from GWAS Catalog. Then, each gene was curated and categorized according to the type of evidence associated with Crohn’s disease.

Source: Methods

Abstract: Results

We identified 126 genes associated with Crohn’s disease risk by specific experiments. Additionally, 71 genes were recognized associated through GWAS alone, 18 to treatment response, 41 to disease complications, and 81 to related diseases. Bioinformatic analysis of the 126 genes supports their importance in Crohn’s disease and highlights genes associated with specific aspects such as symptoms, drugs, and comorbidities. Importantly, most genes were not included in commercial genetic panels suggesting that Crohn’s disease is genetically underdiagnosed.

Source: Results

Abstract: Conclusions

We identified a total of 126 genes from PubMed and 71 from GWAS that showed evidence of association to diagnosis, 18 to treatment response, and 41 to disease complications in Crohn’s disease. This prioritized gene catalog can be explored at http://victortrevino.bioinformatics.mx/CrohnDisease.

Source: Conclusions
Authors’ abstract

Background

Crohn’s disease is one of the two categories of inflammatory bowel diseases that affect the gastrointestinal tract. The heritability estimate has been reported to be 0.75. Several genes linked to Crohn’s disease risk have been identified using a plethora of strategies such as linkage-based studies, candidate gene association studies, and lately through genome-wide association studies (GWAS). Nevertheless, to our knowledge, a compendium of all the genes that have been associated with CD is lacking.

Methods

We conducted functional analyses of a gene set generated from a systematic review where genes potentially related to CD found in the literature were analyzed and classified depending on the genetic evidence reported and putative biological function. For this, we retrieved and analyzed 2496 abstracts comprising 1067 human genes plus 22 publications regarding 133 genes from GWAS Catalog. Then, each gene was curated and categorized according to the type of evidence associated with Crohn’s disease.

Results

We identified 126 genes associated with Crohn’s disease risk by specific experiments. Additionally, 71 genes were recognized associated through GWAS alone, 18 to treatment response, 41 to disease complications, and 81 to related diseases. Bioinformatic analysis of the 126 genes supports their importance in Crohn’s disease and highlights genes associated with specific aspects such as symptoms, drugs, and comorbidities. Importantly, most genes were not included in commercial genetic panels suggesting that Crohn’s disease is genetically underdiagnosed.

Conclusions

We identified a total of 126 genes from PubMed and 71 from GWAS that showed evidence of association to diagnosis, 18 to treatment response, and 41 to disease complications in Crohn’s disease. This prioritized gene catalog can be explored at http://victortrevino.bioinformatics.mx/CrohnDisease.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12864-022-08491-y.

Publication and source details

Original title: A systematic review and functional bioinformatics analysis of genes associated with Crohn’s disease identify more than 120 related genes

Debora Garza-Hernandez; Maricruz Sepulveda-Villegas; Jose Garcia-Pelaez; Raul Aguirre-Gamboa; Peter L. Lakatos; Karol Estrada; Manuel Martinez-Vazquez; Victor Trevino

BMC Genomics · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T09:30:34.413722+00:00

DOI: 10.1186/s12864-022-08491-y · PMC9008988